Trials / Completed
CompletedNCT00228410
Study Comparing Tigecycline and Vancomycin With Aztreonam in Complicated Skin and Skin Structure Infections
A Multicenter, Randomized, Double-Blind Comparison of the Safety and Efficacy of Tigecycline With Those of Vancomycin With Aztreonam to Treat Complicated Skin and Skin Structure Infections in Hospitalized Patients.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 503 (actual)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To compare the safety and the efficacy of tigecycline to vancomycin with aztreonam in treating hospitalized patients with complicated skin and/or skin structure infections.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tigecycline | |
| DRUG | vancomycin with aztreonam |
Timeline
- Start date
- 2002-11-01
- Primary completion
- 2003-12-01
- Completion
- 2003-12-01
- First posted
- 2005-09-28
- Last updated
- 2013-02-08
Source: ClinicalTrials.gov record NCT00228410. Inclusion in this directory is not an endorsement.